Viewing Study NCT00616161


Ignite Creation Date: 2025-12-24 @ 12:03 PM
Ignite Modification Date: 2025-12-27 @ 4:06 PM
Study NCT ID: NCT00616161
Status: COMPLETED
Last Update Posted: 2008-02-15
First Post: 2008-02-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic Function
Sponsor: sigma-tau i.f.r. S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module